Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists

Q4 Medicine

US endocrinology Pub Date : 2020-01-01 DOI:10.17925/USE.2020.16.2.80

E. Cox, R. Alicic, Joshua J. Neumiller, K. Tuttle, Spokane Wa Usa Services, Wa Usa Seattle

引用次数: 3

Abstract

查看原文本刊更多论文

胰高血糖素样肽-1受体激动剂对心血管和肾脏有益的临床证据和拟议机制

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

US endocrinology Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

1.90

自引率

0.00%

发文量